Order Entry
United States
ContactUsLinkComponent
CellGenix® GMP DC Medium, CellGenix
CellGenix® GMP DC Medium, CellGenix
Catalog # MSPP-208010500
Supplier:  Avantor
CAS Number:  
CellGenix® GMP DC Medium, CellGenix
Catalog # MSPP-208010500
Supplier:  Avantor
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Pack type:
    Bottle
  • Description:
    CellGenix® GMP DC medium
  • Size:
    500 ml
  • Environmentally Preferable:
  • Cat. No.:
    MSPP-208010500
  • Supplier no.:
    20801-0500

Specifications

About this item

CellGenix GMP DC is an optimized, serum-free medium used for the generation of human dendritic cells (DCs). It promotes high yields of mature dendritic cells with the desired phenotype.

  • Serum-free cell culture conditions
  • Optimized formulation for the generation of DCs
  • FDA drug master file available

CellGenix GMP DC is optimized for the differentiation of CD14+ monocytes into mature DCs. It is used for the generation of dendritic cell therapies, which represent a new and promising immunotherapeutic approach for treatment of different types of cancer.

Application includes differentiation of CD14+ monocytes into DCs and differentiation of CD14+ monocytes into macrophages.

Certifications: Accordance with USP 1043 and ISO 20399.